Registration for a live webinar on 'Neuroleptic malignant syndrome' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- The amount of iron in the body is tightly regulated
- Definition of hemochromatosis
- Diagnosis of iron overload
- Key iron overload disorders (1)
- Key iron overload disorders (2)
- Hereditary hemochromatosis: endocrine disorder
- Clinical aspects - The past
- Clinical consequences
- Survival curve of hereditary hemochromatosis
- Diseases affecting patients survival
- The effect of cirrhosis on patients' survival
- Clinical aspects - The present
- Mortality due to hereditary hemochromatosis
- Mutations in the HFE gene and disease
- Mutations in the HFE gene are common
- Elevation of serum iron is common
- The dilemma of elevated ferritin levels (1)
- The dilemma of elevated ferritin levels (2)
- Cross sectional population studies
- The controversy of phenotypes and genotypes
- Longitudinal population studies (1)
- Longitudinal population studies (2)
- Longitudinal population studies (3)
- Longitudinal population studies (4)
- The HealthIron sub-study
- HealthIron clinic recruitment
- Untreated hemochromatosis progression
- Probability of serum ferritin rise in males
- Probability of serum ferritin rise in females
- Clinical penetrance
- Iron overload-related disease (1)
- Iron overload-related disease (2)
- Compound heterozygotes
- C282Y homozygotes with ferritin <1000
- HFE and cancer
- Genetic and environmental modifiers
- CYBRD1: a new potent genetic modifier
- Take home message
- Iron-overload evaluation algorithms (1)
- Iron-overload evaluation algorithms (2)
Topics Covered
- Hereditary haemochromatosis
- Iron metabolism
- Definition
- Diagnosis
- Clinical and biochemical penetrance
- Genetic and environmental modifiers
- Diagnostic algorithm
- Update talk: Treatment improves symptoms
- Update talk: C282Y homozygotes & elevated ferritin
- Update talk: New markers for HH detection
- Update talk: Use of MCV and MCH
- Update talk: Arthritis risk in HH
- Update talk: Detection of hepatic fibrosis
- Update talk: Risk of liver cancer
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Olynyk, J.K. (2021, May 31). Hereditary hemochromatosis: what have we learnt from population studies [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved October 5, 2024, from https://doi.org/10.69645/LGAV5707.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial/financial matters to disclose.
Update Available
The speaker addresses developments since the publication of the original talk. We recommend listening to the associated update as well as the lecture.
- Full lecture Duration: 34:27 min
- Update Duration: 8:57 min
Hereditary hemochromatosis: what have we learnt from population studies
A selection of talks on Gastroenterology & Nephrology
Transcript
Please wait while the transcript is being prepared...
0:00
My name is John Olynyk,
I'm professor of gastroenterology at
the University of Western Australia and the Department of Gastroenterology
at Fremantle Hospital.
Today I'm going to discuss issues relating to
hereditary hemochromatosis, and what we have learned from population studies.
0:20
First, I would like to review normal iron homeostasis.
The amount of iron in the body is tightly regulated.
The average individual has about four grams of iron in their body,
of which 2,400 milligrams is in a utilization pool divided between the muscle,
bone marrow and circulating erythrocytes
(which comprise the greatest pool of use in the body),
and 1,600 milligrams in storage,
of which the liver contains the greatest storage deposits,
followed by the reticuloendothelial macrophages.
I'd like to contrast this with the amount of iron absorbed each day,
which is only 1 to 2 mg on average
and is balanced by losses.
Thus we can see that iron is highly conserved within the body, and tightly regulated.
1:10
Having an understanding about what comprises normal body iron stores
I'd now like to move on to discuss the definition of hemochromatosis,
which can be taken as any disorder that is characterized
by tissue injury due to iron overload in many organs.
1:28
How do we diagnose iron overload?
Iron overload can be suspected on the basis of
clinical assessment, based on history and examination findings.
Iron overload can also be suspected on the basis of
abnormal serum iron studies, with elevation of the transferrin saturation or ferritin.
Iron overload can be determined by measurement of the hepatic iron concentration (HIC),
and this can be achieved either biochemically (by measuring
iron content in liver tissue following liver biopsy)
or non-invasively (using a range of technologies of
which magnetic resonance imaging - MRI - is the most practical).
Finally, iron overload can be suspected on the basis of quantitative phlebotomy,
where serial phlebotomy has been undertaken, iron stores
have been reduced, and the amount of iron removed
from the body can be calculated retrospectively.
Hide